Publications, thought leadership & studies

Asia-Pacific Health Industries Newsletter - August 2015

September 29, 2015

In this issue, we cover healthcare market trends and challenges, M&A trends, and regulatory developments in the Asia-Pacific region.

Challenges and Change: A report on the Australian pharmaceutical industry

September 23, 2015

The 2015 PwC pharmaceutical industry survey captures the collective views of the Australian pharma sector and explores the industry's key challenges, trends and opportunities.

Asia-Pacific Health Industries Newsletter - April 2015

May 04, 2015

PwC's Global Health Industries network is pleased to present you with its 13th issue of the Asia-Pacific Health Industries Newsletter.

2015 State of the Internal Audit Profession - Finding true north in a period of rapid transformation

April 16, 2015

PwC’s 2015 State of the Internal Audit Profession Study reflects the views of more than 1300 chief audit executives, senior management and board members.

Asia-Pacific Health Industries Newsletter

December 23, 2014

PwC's Global Health Industries network is pleased to present you with its 12th issue of the Asia-Pacific Health Industries Newsletter.

Asia-Pacific Health Industries Newsletter – July 2014

July 25, 2014

In this edition we highlight recent developments in Asia and Australia including changes in China's compliance and pricing environment, pharmaceutical deals in South Korea and India, digital health, Big Data, and tax developments in Australia, Hong Kong, China and Singapore.

R&D outsourcing in hi-tech industries. A research study.

June 26, 2014

PwC researches pharma relationship performance in large scale clinical outsourcing and lessons from R&D outsourcing in other hi-tech industries.

Managing innovation in pharma

May 16, 2014

This PwC publications surveys pharmaceutical executives across the pharmaceutical value chain about the challenges on innovation in the sector.

Transfer pricing symptoms of chronic industry challenges

October 23, 2013

This article lays out these and other key issues you may be facing, and offers guidance on how to bring your transfer pricing strategies up to date - while managing the expectations of multiple stakeholders.

Asia-Pacific Pharma & Life Sciences Newsletter – March 2013

March 22, 2013

This PwC publication provies news and analysis for pharmaceutical, biotechnology, medical device, diagnostic and healthcare companies.

Pharma 2020 report: From vision to decision

November 15, 2012

In this report, we focus on how companies can reach 2020 in a position to benefit from more favourable conditions thereafter.

Asia-Pacific Pharma & Life Sciences Newsletter – August 2012

August 01, 2012

Asia-Pacific Pharma Newsletter, Issue 9, covers compliance updates in Australia, government price cuts in the region and tax issues in Australia, China, India, Taiwan and Singapore.

Asia Pharmaceutical Newsletter - April 2012

April 30, 2012

This PwC newsletter includes reports on the recent Indian and Singapore Budgets and the implications for multinationals and the local Pharma and Healthcare sectors.

Taking advantage of the Medtech market potential in India: success will hinge on operating model innovation

April 30, 2012

PwC recently surveyed executives from leading global and domestic Medtech companies with India operations representing $1.3 billion in revenues in India, or roughly 40% of the $3 billion Indian market. Their responses, combined with in-depth interviews and PwC’s research and experience in the industry, provide insight on how to succeed in India.

Introducing the Pharma 2020 series

January 16, 2012

PwC's Pharma 2020 series reports look into the future of the Pharmaceuticals and Life Sciences’ value chain, and they include an analysis of the strategies needed to compete successfully in the future.

Diagnostics 2011: M&A surges, companion diagnostics accelerate, and early detection offers new prospects

December 05, 2011

PwC’s Diagnostics 2011 provides an overview of M&A deal activity during the past two years and the factors driving it, including the advance of personalised medicine and testing for earlier detection of diseases, such as cancer and Alzheimer’s. The report also includes an in-depth discussion about trends in companion diagnostics and business model considerations for pharmaceutical companies.

Pharma 2020: Supplying the future -- Which path will you take?

February 20, 2011

PwC's report discusses how pharma companies must develop different supply chain models for different product types and patient segments, use their supply chains for market differentiation and see the role information plays to drive the flow of products and services.

Pharma and Life Sciences Tax News: Vol. 10, No. 2: Puerto Rico’s new excise tax and income source rules: Final regulations issued

January 25, 2011

Puerto Rico issued final regulations December 29, 2010, under Act 154, which modifies Puerto Rican (PR) tax law by adopting new source-of-income rules and imposing a temporary excise tax on certain purchases by offshore companies whose gross receipts exceed $75 million. The new regulations follow the signing of Act 154 by Governor Luis G. Fortuño October 25, 2010, during a rare weekend legislative session. The law, enacted as part of a tax reform initiative, could raise an estimated $5.8 billion over the next six years.

Clinical trials in Poland - Key challenges

December 08, 2010

Poland remains the largest clinical trials market in CEE/CIS, however, both patient participation and site penetration rates indicate a potential for growth. Launching a number of initiatives will accelerate the market growth and maximize the potential benefits to the economy.

Biotech reinvented: Where do you go from here?

November 02, 2010

Biotech reinvented